Ig NextGen 10%

· CSL Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ig NextGen 10%, covering 2012-06-07 to 2016-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 3]